Abdulla Z, Mineur Y, Crouse R, Etherington I, Yousuf H, Na J
Neuropsychopharmacology. 2024; 50(2):488-496.
PMID: 39362985
PMC: 11631976.
DOI: 10.1038/s41386-024-02003-0.
Vaidya S, Guerin A, Walker L, Lawrence A
CNS Drugs. 2022; 36(11):1171-1206.
PMID: 36269510
PMC: 9653329.
DOI: 10.1007/s40263-022-00964-8.
Nabulsi L, Farrell J, McPhilemy G, Kilmartin L, Dauvermann M, Akudjedu T
Neuropsychopharmacology. 2022; 47(9):1643-1651.
PMID: 35046509
PMC: 9283431.
DOI: 10.1038/s41386-022-01268-7.
Fitzgerald P, Hale P, Ghimire A, Watson B
Front Behav Neurosci. 2021; 14:620119.
PMID: 33519395
PMC: 7840590.
DOI: 10.3389/fnbeh.2020.620119.
Cope Z, Lavadia M, Joosen A, van de Cappelle C, Lara J, Huval A
Cogn Affect Behav Neurosci. 2020; 20(6):1173-1183.
PMID: 32794101
PMC: 7718303.
DOI: 10.3758/s13415-020-00824-2.
The cholinesterase inhibitor donepezil has antidepressant-like properties in the mouse forced swim test.
Fitzgerald P, Hale P, Ghimire A, Watson B
Transl Psychiatry. 2020; 10(1):255.
PMID: 32712627
PMC: 7382650.
DOI: 10.1038/s41398-020-00928-w.
Cholinergic regulation of mood: from basic and clinical studies to emerging therapeutics.
Dulawa S, Janowsky D
Mol Psychiatry. 2018; 24(5):694-709.
PMID: 30120418
PMC: 7192315.
DOI: 10.1038/s41380-018-0219-x.
The Role of Muscarinic Receptors in the Pathophysiology of Mood Disorders: A Potential Novel Treatment?.
Jeon W, Dean B, Scarr E, Gibbons A
Curr Neuropharmacol. 2015; 13(6):739-49.
PMID: 26630954
PMC: 4759313.
DOI: 10.2174/1570159x13666150612230045.
Pretreatment Differences in BOLD Response to Emotional Faces Correlate with Antidepressant Response to Scopolamine.
Furey M, Drevets W, Szczepanik J, Khanna A, Nugent A, Zarate Jr C
Int J Neuropsychopharmacol. 2015; 18(8).
PMID: 25820840
PMC: 4571629.
DOI: 10.1093/ijnp/pyv028.
Pulsed intravenous administration of scopolamine produces rapid antidepressant effects and modest side effects.
Furey M, Zarate Jr C
J Clin Psychiatry. 2013; 74(8):850-1.
PMID: 24021505
PMC: 5014541.
DOI: 10.4088/JCP.13ac08584.
A randomized, 4-week double-blind placebo control study on the efficacy of donepezil augmentation of lithium for treatment of acute mania.
Chen J, Lu Z, Zhang M, Zhang J, Ni X, Jiang X
Neuropsychiatr Dis Treat. 2013; 9:839-45.
PMID: 23807849
PMC: 3688436.
DOI: 10.2147/NDT.S40503.
Potential therapeutic uses of mecamylamine and its stereoisomers.
Nickell J, Grinevich V, Siripurapu K, Smith A, Dwoskin L
Pharmacol Biochem Behav. 2013; 108:28-43.
PMID: 23603417
PMC: 3690754.
DOI: 10.1016/j.pbb.2013.04.005.
Human biomarkers of rapid antidepressant effects.
Zarate Jr C, Mathews D, Furey M
Biol Psychiatry. 2013; 73(12):1142-55.
PMID: 23374639
PMC: 3672383.
DOI: 10.1016/j.biopsych.2012.11.031.
Potential of pretreatment neural activity in the visual cortex during emotional processing to predict treatment response to scopolamine in major depressive disorder.
Furey M, Drevets W, Hoffman E, Frankel E, Speer A, Zarate Jr C
JAMA Psychiatry. 2013; 70(3):280-90.
PMID: 23364679
PMC: 3717361.
DOI: 10.1001/2013.jamapsychiatry.60.
Muscarinic receptors: their roles in disorders of the central nervous system and potential as therapeutic targets.
Scarr E
CNS Neurosci Ther. 2011; 18(5):369-79.
PMID: 22070219
PMC: 6493542.
DOI: 10.1111/j.1755-5949.2011.00249.x.
The prominent role of stimulus processing: cholinergic function and dysfunction in cognition.
Furey M
Curr Opin Neurol. 2011; 24(4):364-70.
PMID: 21725241
PMC: 3264402.
DOI: 10.1097/WCO.0b013e328348bda5.
Genetic variation in cholinergic muscarinic-2 receptor gene modulates M2 receptor binding in vivo and accounts for reduced binding in bipolar disorder.
Cannon D, Klaver J, Gandhi S, Solorio G, Peck S, Erickson K
Mol Psychiatry. 2010; 16(4):407-18.
PMID: 20351719
PMC: 2895691.
DOI: 10.1038/mp.2010.24.
The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not beta2- or alpha7-nicotinic acetylcholine receptor subunit knockout mice.
Rabenstein R, Caldarone B, Picciotto M
Psychopharmacology (Berl). 2006; 189(3):395-401.
PMID: 17016705
DOI: 10.1007/s00213-006-0568-z.
Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial.
Furey M, Drevets W
Arch Gen Psychiatry. 2006; 63(10):1121-9.
PMID: 17015814
PMC: 3250308.
DOI: 10.1001/archpsyc.63.10.1121.
Donepezil and related cholinesterase inhibitors as mood and behavioral controlling agents.
Burt T
Curr Psychiatry Rep. 2000; 2(6):473-8.
PMID: 11122998
DOI: 10.1007/s11920-000-0005-7.
